Activated T cells die when antigen disappears from animals. This death is caused by proteins related to Bcl-2. Two hypotheses have been suggested to explain the actions of the different types of Bcl-2 proteins. One hypothesis suggests that, when T cells prepare to die, Bak and Bax, the proteins that actually kill activated T cells, are released from antiapoptotic proteins such as Bcl-2 and Bcl-xl. Another hypothesis suggests that Bak and Bax are normally free and are triggered to kill cells by release of messenger proteins, such as Bim, from Bcl-2 and Bcl-xl. Here, a form of Bcl-xl, which lacks a long unstructured loop, is used to show that the first hypothesis is not correct. Bcl-xl without its loop protects activated T cells from death, yet Bcl-xl without its loop cannot bind any form of Bak and Bax. Thus, binding of Bcl-xl to Bak or Bax is not involved in T cell life or death. The loop of Bcl-xl is also somewhat involved in Bcl-xl's binding of Bim because Bcl-xl without its loop binds Bim less well than wild-type Bcl-xl. Moreover, the loop may have additional, as yet unknown, functions because it changes its shape when Bcl-xl binds Bim.
Skip Nav Destination
Article navigation
25 December 2006
Article|
December 11 2006
Bcl-xl does not have to bind Bax to protect T cells from death
Xinqi Liu,
Xinqi Liu
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
Yanan Zhu,
Yanan Zhu
3Department of Biochemistry and Molecular Genetics and
Search for other works by this author on:
Shaodong Dai,
Shaodong Dai
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
Janice White,
Janice White
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
Fred Peyerl,
Fred Peyerl
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Search for other works by this author on:
John W. Kappler,
John W. Kappler
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
4Program in Biomolecular Structure, Department of Pharmacology, University of Colorado Health Science Center, Denver, CO 80262
Search for other works by this author on:
Philippa Marrack
Philippa Marrack
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
3Department of Biochemistry and Molecular Genetics and
Search for other works by this author on:
Xinqi Liu
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Yanan Zhu
3Department of Biochemistry and Molecular Genetics and
Shaodong Dai
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Janice White
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
Fred Peyerl
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
John W. Kappler
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
4Program in Biomolecular Structure, Department of Pharmacology, University of Colorado Health Science Center, Denver, CO 80262
Philippa Marrack
1Howard Hughes Medical Institute and
2Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206
3Department of Biochemistry and Molecular Genetics and
CORRESPONDENCE Philippa Marrack: [email protected] OR John W. Kappler [email protected]
Abbreviations used: BH3, Bcl-2 homology 3; SEB, staphylococcal enterotoxin B.
X. Liu's present address is Dept. of Biological Science, Purdue University, West Lafayette, IN 47907.
Y. Zhu's present address is Dept. of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143.
Received:
May 31 2006
Accepted:
November 26 2006
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2006
J Exp Med (2006) 203 (13): 2953–2961.
Article history
Received:
May 31 2006
Accepted:
November 26 2006
Citation
Xinqi Liu, Yanan Zhu, Shaodong Dai, Janice White, Fred Peyerl, John W. Kappler, Philippa Marrack; Bcl-xl does not have to bind Bax to protect T cells from death . J Exp Med 25 December 2006; 203 (13): 2953–2961. doi: https://doi.org/10.1084/jem.20061151
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement